Skip to main content

Table 2 Patients’ endothelial biomarkers in the first 3 days

From: Prognostic value of endothelial biomarkers in refractory cardiogenic shock with ECLS: a prospective monocentric study

Biomarker

All Patients (n = 23)

Non-Survivors (n = 10)

Survivors (n = 13)

P value

Thrombomodulin (ng/mL)

 Day 0

5.9 (2.4)

6.3 (1.9)

5.6 (1.8)

0.420

 Day 1

6.3 (1.9)

6.0 (1.9)

6.7 (1.6)

0.535

 Day 2

7.5 (2.7)

6.8 (3.0)

7.5 (2.2)

0.215

Angiopoietin-1 (ng/mL)

 Day 0

29.0 (16.1)

30.8 (13.0)

22.1 (18.7)

0.203

 Day 1

24.9 (17.1)

24.2 (8.8)

26.2 (15.8)

0.107

 Day 2

20.7 (13.8)

20.1 (6.6)

22.2 (9.5)

0.172

Angiopoietin-2 (ng/mL)

 Day 0

19.2 (24.8)

24.4 (58.2)

15.7 (23.2)

0.035

 Day 1

24.7 (35.3)

25.6 (29.0)

17.7 (26.6)

0.137

 Day 2

22.7 (15.4)

23.7 (14.7)

20.3 (9.2)

0.577

VEGF (pg/mL)

 Day 0

8.5 (13.7)

15.3 (32.4)

7.9 (2.1)

0.071

 Day 1

33.0 (65.0)

24.2 (37.6)

35.6 (58.1)

0.438

 Day 2

62.1 (119.2)

24.2 (33.9)

119.9 (105.8)

0.005

Ang-2/Ang-1 ratio

 Day 0

0.82 (1.82)

0.90 (1.53)

0.71 (2.20)

0.470

 Day 1

1.01 (1.74)

1.01 (3.67)

0.79 (1.95)

0.342

 Day 2

1.09 (0.64)

1.10 (0.21)

1.02 (1.54)

0.763

  1. Data were presented median (interquartile); VEGF vascular endothelial growth factor, Ang angiopoietin